$GEN Cashflow Statement | Understand Stock

$GEN

$24.25 -$0.16 (0.66%) Close

$GEN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to Apr 3, 2026	FY2025 12 months to Mar 28, 2025	FY2024 12 months to Mar 29, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Apr 1, 2022
OPERATING ACTIVITIES:
Net income (loss)
Adjustments:
Amortization and depreciation
Impairments and write-offs of current and long-lived assets
Stock-based compensation expense
Loss on sale of Instacash Advances
Deferred income taxes
Loss on extinguishment of debt
Loss from equity interest
Gain on divestitures
Gain on sale of equity method investment
Gain on sale of property
Gain on sale of nonfinancial assets
Gain on sale of properties
Non-cash operating lease expense
Change in fair value and impairment of non-marketable equity investments
Foreign currency remeasurement loss (gain)
Legal contract dispute cost
Other
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net
Accounts payable
Accrued compensation and benefits
Contract liabilities
Income taxes payable
Instacash Advances held for sale, net
Other assets
Other liabilities

Net cash provided by (used in) operating activities
INVESTING ACTIVITIES:
Purchases of property and equipment
Purchase of non-marketable equity investments
Payments for acquisitions, net of cash acquired
Proceeds from divestitures, net of cash contributed and transaction costs
Payments for originations of notes receivable
Proceeds from principal repayments of notes receivable
Proceeds from the maturities and sales of short-term investments
Proceeds from the sale of properties
Proceeds from sale of equity method investment
Proceeds from sale of nonfinancial assets
Other
Net cash provided by (used in) investing activities

FINANCING ACTIVITIES:
Repayments of debt
Proceeds from issuance of debt, net of issuance costs
Net proceeds from sales of common stock under employee stock incentive plans
Tax payments related to vesting of stock units
Dividends and dividend equivalents paid
Repurchases of common stock
Cash consideration paid in exchange of convertible debt
Short-swing profit disgorgement
Other
Net cash provided by (used in) financing activities

Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash
Change in cash, cash equivalents and restricted cash
Beginning cash, cash equivalents and restricted cash
Ending cash, cash equivalents and restricted cash

Comments